Preparing for Data-Enabled Clinical Trial QA Oversight
At ADAMAS, we help sponsors turn clinical trial data into smarter, risk-based quality oversight.
As ICH E6(R3) and the FDA’s Real-Time Clinical Trials initiative reshape clinical trial quality expectations, QA teams need more than dashboards—they need a structured, inspection-ready approach to identifying, interpreting, and acting on emerging risk signals.
Download this free guide to learn how to:
- Build a data-enabled, risk-based QA oversight model
- Define meaningful CTQs, KRIs, and QTLs
- Turn emerging risk signals into documented quality decisions
- Strengthen oversight of outsourced trial activities
- Improve inspection readiness with traceable, compliant QA processes
